Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-26-000106

Chief Executive Officer gave up 28,686 shares (to pay taxes)

  • Chief Executive Officer acquired 35,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Chief Executive Officer 2026-07-28 Option exercise +35,000 $47.60 $1,666,000 100,799 D: show line 1 in the form
Kelderman Kim Chief Executive Officer 2026-07-28 Shares withheld for taxes −28,686 $72.07 $2,067,400 72,113 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kelderman Kim Chief Executive Officer 2026-07-28 Option exercise · Stock Option (Right to Buy) −35,000 0 D: show line 3 in the form
Loading xslF345X06/form4.xml…